Clinical Trial Update: A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing safety and efficacy of MIM-D3 ophthalmic solution for dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• MIM-D3

Snippet

Sponsor: Mimetogen Pharmaceuticals USA, Inc. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED